Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats-Reference-Cited by-同舟云学术

Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats

Published:2019-08 Issue: Volume:567 Page:118458
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Nagai Nobuhiro^ORCID,Nezhad Zhaleh Kashkouli,Daigaku Reiko,Saijo Saaya,Song Yuanhui,Terata Keiko,Hoshi Ayako,Nishizawa Matsuhiko,Nakazawa Toru,Kaji Hirokazu,Abe Toshiaki

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference33 articles.

1. Transscleral drug delivery to the retina and choroid;Ambati;Prog. Retin Eye Res.,2002

2. Advanced drug delivery and targeting technologies for the ocular diseases;Barar;Bioimpacts,2016

3. Molecular pathology of age-related macular degeneration;Ding;Prog. Retin Eye Res.,2009

4. Transscleral drug delivery for posterior segment disease;Geroski;Adv. Drug Deliv. Rev.,2001

5. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study;Jaffe;Ophthalmology,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in ophthalmic therapeutic delivery: A comprehensive overview of present and future directions;Survey of Ophthalmology;2024-11

2. Solid implantable devices for sustained drug delivery;Advanced Drug Delivery Reviews;2023-08

3. Recent advances and future prospects: Current status and challenges of the intraocular injection of drugs for vitreoretinal diseases;Advanced Drug Delivery Reviews;2023-07

4. A comparative study between a transscleral sustained-release device and eyedrops on intraocular distribution of carteolol hydrochloride;Heliyon;2023-03

5. Implantable sustained-release drug delivery systems: a revolution for ocular therapeutics;International Ophthalmology;2023-01-30